Mitochondria and diabetes. An intriguing pathogenetic role.
Philip Newsholme1, Celine Gaudel, Maurico Krause
1UCD School of Biomolecular and Biomedical Science, Belfield, Dublin 4, Ireland. philip.newsholme@ucd.ie
Advances in Experimental Medicine and Biology
|March 9, 2012
Summary
Mitochondrial dysfunction, not rare genetic defects, contributes to metabolic diseases like type 2 diabetes and aging. This review explores mitochondrial roles in energy metabolism and disease pathology.
Area of Science:
- Cellular Biology
- Metabolic Disease Research
- Aging Studies
Background:
- Mitochondria are crucial for ATP production in vital tissues.
- Mitochondrial DNA (mDNA) disorders are rare but severe.
- Rising metabolic diseases suggest broader mitochondrial dysfunction.
Purpose of the Study:
- To review the molecular basis of mitochondrial function and dysfunction.
- To correlate mitochondrial dysfunction with metabolic diseases and aging.
- To understand the role of mitochondria in energy metabolism defects.
Main Methods:
- Literature review of molecular mechanisms.
- Correlation analysis of mitochondrial function with disease pathology.
- Examination of mitochondrial roles in skeletal muscle, pancreatic beta cells, and aging.
Main Results:
- Mitochondrial dysfunction, not just mDNA defects, is linked to metabolic diseases.
- Reduced ATP generation and mitochondrial number/function are implicated in type 2 diabetes and aging.
- Mitochondrial reactive oxygen species (ROS) generation contributes to insulin resistance and muscle dysfunction.
Conclusions:
- Mitochondrial dysfunction is a key factor in prevalent metabolic diseases and aging.
- Understanding these mechanisms is vital for developing therapeutic strategies.
- Further research into mitochondrial health is critical for combating metabolic disorders.
More Related Videos
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...